老年炎症性肠病轻度内镜活动与不良结局相关
本研究回顾性分析504例≥60岁炎症性肠病(IBD)患者,内镜下轻度活动者占38.1%,内镜缓解者占61.9%。多变量分析显示,轻度内镜活动与1年IBD特异性不良结局(aOR 4.16,95%CI 2.10-8.24)及1年发病率相关事件(aOR 1.56,95%CI 1.01-2.43)风险升高相关,且IBD特异性风险持续至5年。
要点
- 老年IBD患者内镜轻度活动者1年IBD特异性不良结局风险显著高于内镜缓解者。
- 轻度内镜活动亦与1年总体发病率相关事件风险轻度升高相关。
- IBD特异性不良结局风险在5年时仍持续存在。
核心结论
- 在老年IBD患者中,与内镜缓解相比,轻度内镜疾病活动与1年IBD特异性及发病率相关不良结局风险升高相关,且IBD特异性风险持续至5年。
研究设计与样本
- 回顾性研究纳入504例≥60岁、2018年1月1日至2023年1月1日内镜检查示轻度或无疾病活动的IBD患者,中位病程11年。
主要发现
- 192例(38.1%)患者为轻度内镜疾病活动,312例(61.9%)为内镜缓解。
- 多变量分析显示,轻度内镜活动增加1年IBD特异性不良结局风险(aOR 4.16,95%CI 2.10-8.24),5年结果相似。
- 轻度内镜活动增加1年发病率相关事件风险(aOR 1.56,95%CI 1.01-2.43)。
临床怎么用
- 对老年IBD患者应重视实现内镜缓解,因其可能带来短期和长期获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The benefits of achieving endoscopic remission among older adults with inflammatory bowel disease (IBD) who have mild persistent disease activity are unknown. METHODS: This was a retrospective study of adults ≥ 60 with IBD who had mild or no disease activity on endoscopy from January 1, 2018-January 1, 2023. The primary outcome was a composite of major IBD-specific adverse events (hospitalizations, surgery, and prescription of corticosteroids for IBD-related symptoms) within 1 year of endoscopic assessment. Our secondary outcome was a composite of 1-year morbidity-related events (mortality, all-cause hospitalization, infection requiring antibiotics, venous thromboembolism, cardiovascular events, and osteoporotic fractures). We also assessed outcomes at 5 years. RESULTS: Among 504 patients, 192 (38.1%) had mild endoscopic disease and 312 (61.9%) were in endoscopic remission, with a median disease duration of 11 years. On multivariable analysis, mild endoscopic disease activity increased the odds of a 1-year adverse IBD-specific outcome (aOR 4.16, 95% CI 2.10-8.24), with similar results at 5 years. Furthermore, mild endoscopic disease was associated with increased odds of experiencing an adverse morbidity-related outcome within 1 year as compared to endoscopic remission (aOR 1.56, 95% CI 1.01-2.43). CONCLUSIONS: Among older adults with prevalent IBD, mild endoscopic disease activity, as compared to endoscopic remission, was associated with increased odds of adverse IBD-specific and morbidity-related outcomes at 1 year, with this risk persisting for IBD-specific outcomes at 5 years. These findings highlight the importance of achieving endoscopic remission, which may confer both short- and longer-term benefits in this population.
引用
- Tang CZ, Delau OR, Katz S, et al. Mild Endoscopic Disease Activity Is Associated With Adverse Outcomes Among Older Adults With Inflammatory Bowel Disease. Aliment Pharmacol Ther. 2025. PMID: 41090496. doi:10.1111/apt.70414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。